SCHOTT Pharma AG & Co. KGaA (1SXP.F)

EUR 23.72

(0.08%)

Net Income Summary of SCHOTT Pharma AG & Co. KGaA

  • SCHOTT Pharma AG & Co. KGaA's latest annual net income in 2023 was 151.84 Million EUR , up 21.11% from previous year.
  • SCHOTT Pharma AG & Co. KGaA's latest quarterly net income in 2024 Q2 was 25.03 Million EUR , down -43.63% from previous quarter.
  • SCHOTT Pharma AG & Co. KGaA reported an annual net income of 125.37 Million EUR in 2022, up 24.44% from previous year.
  • SCHOTT Pharma AG & Co. KGaA reported an annual net income of 100.75 Million EUR in 2021, up 30.04% from previous year.
  • SCHOTT Pharma AG & Co. KGaA reported a quarterly net income of 25.03 Million EUR for 2024 Q2, down -43.63% from previous quarter.
  • SCHOTT Pharma AG & Co. KGaA reported a quarterly net income of 46.26 Million EUR for 2024 Q3, up 84.8% from previous quarter.

Annual Net Income Chart of SCHOTT Pharma AG & Co. KGaA (2023 - 2020)

Historical Annual Net Income of SCHOTT Pharma AG & Co. KGaA (2023 - 2020)

Year Net Income Net Income Growth
2023 151.84 Million EUR 21.11%
2022 125.37 Million EUR 24.44%
2021 100.75 Million EUR 30.04%
2020 77.48 Million EUR 0.0%

Peer Net Income Comparison of SCHOTT Pharma AG & Co. KGaA

Name Net Income Net Income Difference
Carl Zeiss Meditec AG 290.39 Million EUR 47.712%
Fielmann Aktiengesellschaft 127.64 Million EUR -18.957%
Gerresheimer AG 116.12 Million EUR -30.756%
Sartorius Aktiengesellschaft 205.2 Million EUR 26.003%
Sartorius Aktiengesellschaft 205.2 Million EUR 26.003%